Entity
Aidoc Medical – AI Diagnostic Platform
Aidoc Medical raised $150M in a Goldman Sachs-led Series C, with Nvidia NVentures, General Catalyst, and SoftBank participating. The company's AI platform helps doctors diagnose patients faster through medical imaging analysis. Nvidia's strategic involvement underscores healthcare AI as a priority vertical.
Importance: 74%Confidence: 90%Mentions: 1Updated: May 2, 2026
## Aidoc Medical – AI Diagnostic Platform
### Overview
Aidoc Medical Ltd. is a startup offering an AI-powered platform designed to help doctors diagnose patients faster by analyzing medical imaging and clinical data (SiliconAngle, April 29).
### Funding
Aidoc secured **$150 million in Series C funding** in April 2026. Goldman Sachs led the round, with participation from Nvidia's NVentures, General Catalyst, and SoftBank Investment Advisors (SiliconAngle, April 29).
### Product
Aidoc's software reportedly analyzes medical imaging data to flag urgent findings and prioritize patient cases for radiologists and clinicians (SiliconAngle, April 29).
### Key Investors
- Goldman Sachs (lead)
- Nvidia NVentures
- General Catalyst
- SoftBank Investment Advisors
### Strategic Context
Nvidia's NVentures participation signals the company's continued strategic investment in healthcare AI as a vertical for GPU-accelerated inference workloads. The Goldman Sachs-led round reflects growing institutional interest in clinical AI platforms with regulatory clearances. Aidoc operates in a space facing increasing FDA scrutiny for AI-based diagnostic tools.